Cargando…
Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice
BACKGROUND: Signal transducer and activator of transcription 3 (STAT3) is usually constitutively activated in a variety of malignancies. Therefore, STAT3 may be a promising target for treatment of tumor cells. To explore the possibility of a double-stranded decoy oligodeoxynucleotide (ODN) targeted...
Autores principales: | Zhang, Xulong, Zhang, Jian, Wang, Lihua, Wei, Haiming, Tian, Zhigang |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1988829/ https://www.ncbi.nlm.nih.gov/pubmed/17683579 http://dx.doi.org/10.1186/1471-2407-7-149 |
Ejemplares similares
-
STAT-1 decoy oligodeoxynucleotide inhibition of acute rejection in mouse heart transplants
por: Stojanovic, Tomislav, et al.
Publicado: (2009) -
Biochemical Properties of a Decoy Oligodeoxynucleotide Inhibitor of STAT3 Transcription Factor
por: Lee, David S., et al.
Publicado: (2018) -
Modeling the therapeutic efficacy of NFκB synthetic decoy oligodeoxynucleotides (ODNs)
por: Wang, Zhipeng, et al.
Publicado: (2018) -
Beneficial effect of STAT3 decoy oligodeoxynucleotide transfection on organ injury and mortality in mice with cecal ligation and puncture-induced sepsis
por: Imbaby, Samar, et al.
Publicado: (2020) -
Exosome-mediated delivery of RBP-J decoy oligodeoxynucleotides ameliorates hepatic fibrosis in mice
por: He, Fei, et al.
Publicado: (2022)